English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 28 January 2019, 08:30 HKT/SGT
Share:
DBS: Leasing Sector Embraces The Super Up-Cycle; Top Buys: Far East Horizon(3360.HK)

HONG KONG, Jan 28, 2019 - (ACN Newswire) - DBS recently issued a research report on China leasing sector, which indicated that it will be set to benefit from China's ongoing deleveraging campaign, continuous expansion in manufacturing and infrastructure FAI. Far East Horizon was listed as top buys, with initiate coverage with BUY and target price of HK$10.3, implying a 35% upside.


DBS pointed out that it should be focused on the profitability changes of Far East Horizon rather than its asset growth as it prefers to be less aggressive in expanding amid macro uncertainties in the future. The core leasing business of Far East Horizon will be benefit from macro-trends changes. Far East Horizon is well positioned in selective segments including urban public utility, healthcare and education, accounting for 59% of its total interest earnings asset in 1H2018. With 70% of its customers coming from state-owned enterprises, Far East Horizon is well balanced between risk and reward of its assets and customers portfolio. It expected that the funding cost of Far East Horizon will continuously benefit from lower market interest rate, and the asset quality will remain benign in 2019.

DBS considered that the deployment in hospital operations of Far East Horizon is also expected to help mitigate the volatility in core leasing business, providing stable income streams and create business synergies. Far East Horizon first entered the hospital-operation business back in 2014. It has been expanding throughout the years and operated 43 medical service institutions in 1H2018. Its total number of hospital beds had reached 16,000, with a 2018 full-year target of reaching 20,000 beds, the hospital operator with the largest bed capacity in China. DBS believed that the profit growth of Far East Horizon will accelerate once it has gained better economies of scale. Furthermore, its deployment in the hospital operation will also help to create synergy, improving industry know-how and credit risk awareness of its financial leasing business.

DBS believed that the share price of Far East Horizon is significantly undervalued, as its current share price reflects zero value of its hospital operation, and the leasing business is also undervalued by the market. Based on SOTP valuation, DBS initiated Far East Horizon with BUY and target price of HK$10.3, which implies a 35% upside.


Topic: Press release summary Sectors: Daily Finance, Daily News
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Spritzer Scores Big with 'Meet the Red Legends' Event for Football Fans  
Apr 28, 2024 18:00 HKT/SGT
Announcing Mad About Marketing - A New Member of the Digital Sukoon Private Limited Family  
Apr 28, 2024 17:00 HKT/SGT
HKTDC unveils gifts, printing, packaging and licensing events  
Apr 27, 2024 20:00 HKT/SGT
Masverse Unveils Groundbreaking Blockchain Platform  
Apr 27, 2024 02:40 HKT/SGT
FinTech Funding Continues to Surge as Second Edition of Dubai FinTech Summit Commences  
Apr 26, 2024 21:10 HKT/SGT
TIME Interconnect Technology Limited Announces Final Results For The Nine Months Ended 31 December 2023  
Apr 26, 2024 18:26 HKT/SGT
UK advertising reports GBP36.6bn spend in 2023  
Apr 26, 2024 17:30 HKT/SGT
CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine  
Apr 26, 2024 15:36 HKT/SGT
Edvantage Group Announces FY2024 Interim Results  
Apr 26, 2024 13:43 HKT/SGT
Internationally Renowned Botulinum Toxin Experts Join WizMedi Bio's New Botulinum Toxin Development Project  
Apr 26, 2024 13:27 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575